Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Viela Bio, Inc.
| Metric | Viela Bio, Inc. Healthcare |
|---|---|
| Quality Score | 40 / 100 |
| Revenue (latest) | $12M |
| Net income (latest) | −$151M |
| Operating margin | −1320.6% |
| Net margin | −1293.1% |
| Return on equity | −40.1% |
| Return on assets | −35.6% |
| Return on capital (ROCE) | −40.8% |
| Debt / equity | 0.13× |
| Revenue growth (YoY) | −76.7% |
| Altman Z″ (distress) | 7.91 |
| Accruals / assets | −10.5% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.